Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Milestone Scientific›
Website
AddedFeb 19, 2024
UpdatedJul 3, 2026
Milestone Scientific

Milestone Scientific

Public

Milestone Scientific: NJ-based manufacturer of computer-controlled injection tech for medical and dental care.

HQ
LIVINGSTON, NJ, US
Founded
1989
Loading
Overview
Compare
Fundraising
Employees
Website

Milestone Scientific - Website

An index of every page on milestonescientific.com, by section.

29 pages across 8 sections · Updated Jul 19, 2026·

Homepage

Milestone Scientific's front door: current positioning and top-line messaging.

milestonescientific.com
  • Homepage

Products / ServicesTest Product

The products and services as Milestone Scientific markets them.

  • Test Product/product/test-product
  • Wand Handpiece No Needle Box of 50
  • Wand Sta 1 2 30g Hp Box of 50
  • Wand Sta 1 30g Handpiece Box of 50
  • Wand Sta 1 1 4 27g Handpiece Box of 50
  • Wand Sta Handpiece No Needle Box of 50

Blog

Product updates and company thinking from Milestone Scientific.

milestonescientific.com/blog

Contact

Sales, support, and partnership channels for reaching Milestone Scientific directly.

milestonescientific.com/contact

ComparisonNew Clinical Trial Finds Milestone Scientifics Compuflo Instrument a Safe Alternative to Current Standards of Care

6 comparison pages published by Milestone Scientific.

  • New Clinical Trial Finds Milestone Scientifics Compuflo Instrument a Safe Alternative to Current Standards of Care
  • International Multicenter Study of Accidental Dural Puncture Rate Comparison of the Compuflo with Traditional Method Anesthesiology 2019 Annual Meeting in Orlando Florida
  • International Multicenter Study of Accidental Dural Puncture Rate Comparison of the Compuflo with Traditional Method
  • Compuflo Assisted Training vs Conventional Training for the Identification of the Ligamentum Flavum with an Epidural Simulator a Brief Report
  • Epidural Needle Extension Through the Ligamentum Flavum Using the Standard Versus the Compuflo Assisted Loss of Resistance to Saline Technique a Simulation Study
  • Objective Epidural Space Identification Using Continuous Real Time Pressure Sensing Technology a Randomized Controlled Comparison with Fluoroscopy and Traditional Loss of Resistance

About

Company story, mission, and background as Milestone Scientific tells it.

milestonescientific.com/about
  • Distributors/about/distributors
  • Scientific Advisory Board/about/scientific-advisory-board
  • Board of Directors/about/board-of-directors
  • Management Team/about/management-team
  • Press Events/about/press-events

TeamOlivier Choquet M D

Leadership and the people behind Milestone Scientific, as the company presents them.

  • Olivier Choquet M D/our-team/olivier-choquet-m-d
  • Paul Davis M D/our-team/paul-davis-m-d
  • Ralf Erich Gebhard M D/our-team/ralf-erich-gebhard-m-d
  • Lorrence Howell Green Ph D
  • Mark Hochman D D S/our-team/mark-hochman-d-d-s
  • Samuel B Low/our-team/samuel-b-low

PrivacyPrivacy Policy

How Milestone Scientific collects, uses, and safeguards data: the canonical policy set.

milestonescientific.com/privacy-policy